MINNEAPOLIS, April 27, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq:PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, will host an R&D call on Tuesday, May 03, 2022 at 9:00 AM Eastern Time. Panbela’s management team will be joined by leading experts for a deep dive on the company’s investigational drug, SBP-101, as a polyamine metabolism modulator in ovarian cancer.
Panbela to Host Virtual R&D Day
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here